E
Kalaris Therapeutics, Inc. KLRS
$3.08 $0.5220.31% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 06/30/2024
Net Income -11.32% -65.84%
Total Depreciation and Amortization -- --
Total Amortization of Deferred Charges -100.00% 69.10%
Total Other Non-Cash Items 165.02% 201.78%
Change in Net Operating Assets -175.87% 91.71%
Cash from Operations -68.51% 12.17%
Capital Expenditure -- --
Sale of Property, Plant, and Equipment -- --
Cash Acquisitions -- --
Divestitures -- --
Other Investing Activities -- --
Cash from Investing -- --
Total Debt Issued -100.00% 0.14%
Total Debt Repaid -- --
Issuance of Common Stock -- --
Repurchase of Common Stock -- --
Issuance of Preferred Stock -- -100.00%
Repurchase of Preferred Stock -- --
Total Dividends Paid -- --
Other Financing Activities -100.00% -240.00%
Cash from Financing -100.00% -24.26%
Foreign Exchange rate Adjustments -- --
Miscellaneous Cash Flow Adjustments -- --
Net Change in Cash -112.56% -50.83%